Cathleen Whitty - DrugBank Blog

DrugBank Expands Coverage to Seven New Regions, Grows Global Influence

We are excited to announce that we have expanded our drug products and indications coverage with seven new regions: Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey. This allows DrugBank to better serve global customers and helps existing customers grow into new markets.

Mental Health

Frozen DrugBanker Challenge

We challenged our team to get outside and shake up the work from home routine. This challenge was how we stayed connected while working remotely, took mental health breaks, and explored our cities even when it was too cold.

Announcements

Introducing the Drug Allergy Module

Our new Drug Allergy Module gives you detailed drug allergy and cross-sensitivities information. You can help your clinical users avoid severe drug allergies and manage mild symptoms with ease.

In the News

DrugBank’s Journey to Fueling Global COVID-19 Antiviral Research

It’s been over a year since COVID-19 emerged and DrugBank has been at the forefront of COVID antiviral research. Our two co-founders, Mike Wilson and Craig Knox, sit down (virtually) with Arden Tse from the Accelerate Fund.

COVID19

Research Spotlight: Repositioning of 8,565 existing drugs for COVID-19

Research Spotlight: Learn how a team of researchers used DrugBank to help narrow the search for potential antiviral candidates in COVID-19.

Feature Announcements

DrugBank Winter 2020 Feature Release

DrugBank is excited to share the Winter 2020 Feature Release. Learn about our exciting updates on similar indications lookup, duplicate therapy checker, filtering generics, web token authentication, demo apps repository, and more.